Charlotte's Web Holdings, Inc.

CWBHF
About the company

Charlotte's Web Holdings, Inc. engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and botanical-based wellness products in the United States. The company offers full-spectrum hemp extract oil tinctures, such as liquid products; gummies; capsules; soft-gels; CBD topical creams and lotions; broad-spectrum botanical CBD; functional mushroom gummies; and pet products.

Country: United StatesPrice: $0.17Market Cap: $47.5M

Investment snapshot

6%positive consensus
Scored 1d ago

Positive

1

BUY / PASS

Neutral / negative

1 / 14

NEUTRAL / FAIL

Median fair value

—

No comparable estimates

Models with upside

0 / 17

Positive margin of safety

Strongest signal

8 of 12 pass — Graham, Buffett, Lynch +1 more object

Key risk

No clean pass — all 16 investors flag at least one profitability criterion

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILFAILFAILFAIL · Rank #2502 (Top 80.8%)PASSFAILFAILFAILFAILFAILFAILFAILFAILFAILFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Annual history · FY 2025

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · Balance sheet at 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-31

Score computed: 2026-11-14

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-31

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-12

Score computed: 2026-11-14

TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-11-12

Score computed: 2026-11-14

Where It Passes

  • Debt & Leverage67% pass✓ 11✗ 4▾

    8 of 12 pass — Graham, Buffett, Lynch +1 more object

    LT Debt vs Net Current Assets
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: N/A (negative equity), IC: N/A
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity0
    ✓Lynch< 0.33
    Cash - Long-term Debt
    ✗LynchPositive preferred
    LT Debt / Total Assets Change0.00% -> 0.00%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities4.16
    ✓Dreman> 1.5✓SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity0
    ✓Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
    Debt Levels0
    ✓MungerDebt/Equity < 0.5✓AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDA
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity0
    ✓Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-0.0000; #1/4210 (top 0.0%)
    ✓AsnessTop 30% of eligible cross-section

Where It Falls Short

  • Profitability0% pass✓ 4✗ 31▾

    No clean pass — all 16 investors flag at least one profitability criterion

    Positive EPS (10 years)0/7 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)0/7 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)-69.4%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)-40.6% (latest)
    ✓BuffettStable or rising over 10 years
    Free Cash Flow Proxy$-24.0M
    ✗BuffettPositive and growing
    Earnings Variance (10-yr CoV)N/A (negative mean EPS)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    ROE-60.5%
    ✗Lynch> 15%
    EBIT / Enterprise Value-22.4%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-22.4%, ROC=-55.8%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets-39.51%
    ✗PiotroskiROA > 0
    ROA Change YoY-26.31% -> -39.51% (delta: -13.20%)
    ✗PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=-18.76%, ROA=-39.51%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY42.8% -> 43.5%
    ✓PiotroskiImproved YoY
    Pre-Tax Income / Revenue-71.7%
    ✗Dreman>= 8%
    Net Income / Shareholders' Equity-60.5%
    ✗Dreman> 12%
    Margin of Safety
    ✗PabraiP/B < 1.5 or P/E < 15
    Return on Equity-76.5% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Positive Net Income Frequency0/6 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue-40.2%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity-60.5%
    ✗Ackman>= 15%
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend-64.3% (2023) -> -40.6% (2025)
    ✓TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendgross margin 56.3% -> 43.5%, operating margin -64.3% -> -40.6%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization-67.66%; #5206/6340 (top 82.1%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets+27.29%; #1574/3702 (top 42.5%)
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity-60.52%; #4318/5226 (top 82.6%)
    ✗AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.2222; #4329/5884 (top 73.6%)
    ✗AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years0/6 years positive
    ✗Schloss>= 70% positive over 5-10 observed years (app rule)
  • Valuation0% pass✓ 1✗ 27▾

    No clean pass — all 13 investors flag at least one valuation criterion

    Price / 3-yr avg EPS
    ✗Graham<= 15x
    Price-to-Book Ratio
    ✗Graham<= 1.5x
    P/E x P/B
    ✗Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value-22.4%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=-22.4%, ROC=-55.8%
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS
    ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    Price / Book Value per ShareN/A (negative BVPS)
    ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessOE Yield=-85.8%
    ✗MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldFCF Yield=-30.9%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical Average
    ✗MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic ValueN/A (negative normalized EPS)
    ✗Marks>= 20% below intrinsic value
    Price / FCF per ShareN/A (negative FCF)
    ✗Ackman<= 25
    Price vs. Trailing Low192% of trailing low ($0.09)
    ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization-67.66%; #5206/6340 (top 82.1%)
    ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+1.1180; #1304/6449 (top 20.2%)
    ✓AsnessTop 30% of eligible cross-section
    Price / Diluted EPS
    ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E
    ✗Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per ShareN/A (non-positive TBVPS)
    ✗SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change
    ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+0.9422; #1832/5247 (top 34.9%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization-30.90%; #3664/4519 (top 81.1%)
    ✗OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-69.83%; #5653/6202 (top 91.1%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Cash Flow0% pass✓ 1✗ 11▾

    No clean pass — all 10 investors flag at least one cash flow criterion

    Free Cash Flow Proxy$-24.0M
    ✗BuffettPositive and growing
    FCF Positive and Growing$-14.7M
    ✗LynchPositive and growing
    Operating Cash Flow$-14.1M
    ✗PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=-18.76%, ROA=-39.51%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)N/A (negative CFPS)
    ✗Dreman< 8x
    P/E or FCF YieldFCF Yield=-30.9%
    ✗PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive0/6 years FCF positive
    ✗MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap-52.5%
    ✗Ackman>= 4%
    Price / FCF per ShareN/A (negative FCF)
    ✗Ackman<= 25
    Positive Operating Cash Flow frequency0/6 years positive
    ✗SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$-14.7M
    ✗Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization-30.90%; #3664/4519 (top 81.1%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Growth0% pass✓ 1✗ 12▾

    No clean pass — all 8 investors flag at least one growth criterion

    EPS Growth (3-yr avg, 10-yr window)N/A (negative base EPS)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)
    ✗Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR
    ✗Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthInv: -23.0% vs Rev: -9.1%
    ✓LynchInventory growth < Revenue growth
    EPS Growth Direction$-0.25 (2020) -> $-0.19 (2025)
    ✗DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency0/6 years positive
    ✗MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth-14.8%
    ✗Ackman>= 5%
    Positive EPS Growth Frequency2/5 years with positive EPS growth
    ✗AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR
    ✗Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendgross margin 56.3% -> 43.5%, operating margin -64.3% -> -40.6%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR-12.1%
    ✗SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR
    ✗Neff7%-20% annualized
  • Verdicts6% pass✓ 1✗ 15▾

    Split decision: 14 FAIL · 1 PASS · 1 NEUTRAL

    Overall verdict
    ✗GrahamFAIL (1/9)✗BuffettFAIL (1/9)✗LynchFAIL (2/7)✗GreenblattRank #2502✓PiotroskiPASS (F-Score 5)✗DremanFAIL (2/11)✗MungerFAIL (1/4)✗PabraiFAIL (0/3)✗AkreFAIL (2/6)✗MarksFAIL (0/5)✗AckmanFAIL (2/9)✗TempletonFAIL (3/8)✗SleepFAIL (1/6)✗AsnessFAIL (Rank #918/2370 (Top 38.7%))✗NeffFAIL (0/6)✗SchlossFAIL (2/7)•OshaughnessyNEUTRAL (Not ranked)
  • Efficiency38% pass✓ 4✗ 7▾

    5 of 8 flag CWBHF's efficiency — Buffett, Greenblatt, Munger +2 more

    Current Ratio4.16
    ✓Graham>= 2.0
    ROIC (3-5 yr avg)-69.4%
    ✗Buffett> 10%
    ROIC - WACC-79.4%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)-55.8%
    ✗Greenblatt> 25%
    Current Ratio Change YoY2.95 -> 3.51
    ✓PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY0.44x -> 0.66x
    ✓PiotroskiImproved YoY
    Current Assets / Current Liabilities4.16
    ✓Dreman> 1.5
    Return on Invested Capital-26.7%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=-32.7%; FY2024: ROIC=-35.7%; FY2025: ROIC=-32.8%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROICN/A (non-positive net income)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/5 years above 12% (latest -32.8%)
    ✗SleepROIC > 12% in a majority of years

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Agriculture
SIC Sector: Agricultural Crops
Size: Micro Cap($47.5M)
Revenue: $49.9M+0.5% YoY
Net Income: $29.7M+0.4% YoY

Financial Snapshot

Operating Margin-40.6%
Return on Equity1458.6%
Debt / Equity-24.94
Current Ratio3.51
EPS (Diluted)$-0.19
Shares Retired−1.1% / −1.7% 2y

Similar Companies

CTVACorteva, Inc.
$6.3B
CALMCAL-MAINE FOODS INC
$3.1B
DOLEDole plc
$1.3B
AGROAdecoagro S.A.
$1.3B

Shareholder Return

Fiscal 2025

Issued 1.1% of shares last year, 1.7% issued over two.

Buybacks
—
Dividends
—

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2026-09-30

2025-10-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, gross profit, ebit, pre tax income, operating cash flow, depreciation amortization, capex.

Q3 FY 2026

2026-07-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, depreciation amortization, capex.

Q2 FY 2026

2026-04-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, depreciation amortization, capex.

Q1 FY 2026

2026-01-01 – 2026-03-31

Sources
FY 2025
Sources
  • 10-K · 2026-03-31
FY 2024
Sources
  • 10-K · 2025-03-19
FY 2023
Sources
  • 10-K · 2024-03-21
FY 2022
Sources
  • 10-K · 2023-03-23
FY 2021
Sources
  • 10-K · 2022-03-24
Market Cap$47.5Mcurrent------$81.4Mest.$17.1Mest.$27.9Mest.$85.4Mest.$144.5Mest.
Revenue$44.7M↓9%$9.4M↓18%$10.9M↓15%$11.2M↓9%$49.9M$49.7M↓21%$63.2M↓15%$74.1M↓23%$96.1M
Operating Income-$18.0M↑11%-$3.7M↑30%-$4.4M↓7%-$4.3M↑19%-$20.3M↑37%-$32.0M↑21%-$40.6M↑23%-$52.5M↑64%-$147.1M
Net Income-$32.1M↓48%-$3.5M↑41%-$4.1M↑34%-$13.1M↓111%-$29.7M-$29.8M↓25%-$23.8M↑60%-$59.3M↑57%-$137.7M
EPS (Diluted)--$-0.01↑75%$-0.02↑50%$-0.08↓100%$-0.19$-0.19↓19%$-0.16↑60%$-0.40↑59%$-0.98
Gross Margin44.2%46.9%↑20%47.5%↑2%46.6%↓8%43.5%↑2%42.8%↓24%56.3%↑115%26.2%↓48%50.6%
Operating Margin-40.2%↑2%-39.3%↑14%-40.1%↓26%-38.7%↑11%-40.6%↑37%-64.4%-64.3%↑9%-70.8%↑54%-153.0%
ROE-60.5%↑74%———1458.6%↑1424%-110.2%↓157%-42.8%↑44%-76.5%↑28%-105.6%
Total Debt$0↓100%$0↓100%$0↓100%$51.5M↑15%$50.8M↑17%$43.6M↑3%$42.5M↑14%$37.4M$0
Shareholders' Equity$53.1M↑474%$53.1M↑474%$56.1M↑276%-$15.0M↓171%-$2.0M↓108%$27.1M↓51%$55.6M↓28%$77.5M↓41%$130.4M
Current Ratio4.16↑7%4.16↑7%4.19↑9%3.35↑41%3.51↑19%2.95↓11%3.31↓32%4.84↑2%4.75
Debt / Equity0.00↓100%0.00↓100%0.00↓100%-3.42↓261%-24.94↓1648%1.61↑110%0.77↑59%0.480.00
Operating Cash Flow-$8.1M↑42%-$2.6M↑53%-$926.0K↑77%-$2.8M-$14.1M↑34%-$21.3M↓38%-$15.4M↓189%-$5.3M↑82%-$29.6M
Free Cash Flow---$2.6M-$955.0K↑77%-$2.8M↑15%-$14.7M↑42%-$25.1M↓32%-$19.1M↓242%-$5.6M↑84%-$34.5M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Agriculture

CWBHF vs Peers — Financial Grading

Revenue$49.9MBottom 25%
Net Income$29.7MBottom 25%
ROE1458.6%Top 25%
D/E-24.94Top 25%
Op. Margin-40.6%Bottom 25%
Curr. Ratio3.51Top 25%
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
Corteva, Inc.CTVA$6.3B$9.43$17.4B$1.1B4.5%0.11—1.435/92/94/73/3F-Score 79/11
CAL-MAINE FOODS INCCALM$3.1B$66.45$2.9B$316.7M12.0%—12.0%7.706/93/92/71/3F-Score 66/11
Dole plcDOLE$1.3B$14.32$9.2B$51.3M3.8%0.632.4%1.174/91/90/71/3F-Score 63/11
Adecoagro S.A.AGRO$1.3B$9.11$1.5B$92.3M6.7%0.5712.0%2.545/92/93/70/3F-Score 76/11
DEL MONTE CORPDMC$1.3B$27.22$4.3B$90.7M4.5%0.093.2%2.165/91/92/70/3F-Score 86/11
Mission Produce, Inc.AVO$1.0B$11.83$1.4B$37.7M6.4%0.164.7%1.952/90/91/70/3F-Score 83/11
CALAVO GROWERS INCCVGW$490.7M$27.63$648.4M$19.8M9.6%0.023.0%2.473/92/91/71/3F-Score 72/11
BrasilAgro - Brazilian Agricultural Real Estate CoLND$311.8M$3.13$160.2M$25.2M6.3%—23.5%—5/93/90/71/3F-Score 54/11